These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16975)

  • 1. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
    Brockway WJ; Fass DN
    J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 3. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
    Caduff T; Straub PW
    Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
    Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ
    Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181
    [No Abstract]   [Full Text] [Related]  

  • 9. Variant forms of von Willebrand's disease: type IIA, type IIB and platelet-type von Willebrand's disease.
    Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1678-89. PubMed ID: 6335811
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions].
    Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L
    Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid assay for von Willebrand factor activity using formalin-fixed platelets and microtitration technic.
    Ramsey R; Evatt BL
    Am J Clin Pathol; 1979 Dec; 72(6):996-9. PubMed ID: 316281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudo-von Willebrand's disease.
    Hoyer LW
    N Engl J Med; 1982 Feb; 306(6):360-2. PubMed ID: 6798443
    [No Abstract]   [Full Text] [Related]  

  • 13. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.
    Meyer D; Jenkins CS; Dreyfus MD; Fressinaud E; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):579-99. PubMed ID: 4549013
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of porcine and human ristocetin-Willebrand factor.
    Olson JD; Brockway WJ; Fass DN; Bowie EJ; Mann KG
    J Lab Clin Med; 1977 Jun; 89(6):1278-94. PubMed ID: 405441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in von Willebrand's disease.
    Ruggeri ZM; Zimmerman TS
    Prog Clin Biol Res; 1981; 72():139-48. PubMed ID: 6801683
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simple rapid test for assaying ristocetin cofactor].
    Aznar JA; Borrego D; Martín G; Jorquera J; Jiménez C; García I; Marty ML
    Sangre (Barc); 1982; 27(5):959-66. PubMed ID: 6984787
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative determination of Willebrand factor activity in Willebrand's disease].
    Buchvarova V; Samama M; Lecrubier C
    Vutr Boles; 1976; 15(3):92-4. PubMed ID: 1086035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.